Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Gains from Investment Securities (2016 - 2026)

Iradimed has reported Gains from Investment Securities over the past 14 years, most recently at $50000.0 for Q1 2026.

  • Quarterly Gains from Investment Securities rose 455.56% to $50000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.0 million through Mar 2026, down 15.37% year-over-year, with the annual reading at $17876.0 for FY2025, 45.66% up from the prior year.
  • Gains from Investment Securities was $50000.0 for Q1 2026 at Iradimed, down from $1.4 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $6.5 million in Q4 2024 and troughed at $70.0 in Q2 2023.
  • The 5-year median for Gains from Investment Securities is $26836.0 (2022), against an average of $661736.8.
  • Year-over-year, Gains from Investment Securities tumbled 99.23% in 2023 and then surged 186214.29% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.7 million in 2022, then dropped by 28.85% to $1.2 million in 2023, then soared by 435.05% to $6.5 million in 2024, then crashed by 78.12% to $1.4 million in 2025, then plummeted by 96.49% to $50000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Gains from Investment Securities are $50000.0 (Q1 2026), $1.4 million (Q4 2025), and $6104.0 (Q3 2025).